Lawrence C. LaPointe

1.2k total citations
20 papers, 907 citations indexed

About

Lawrence C. LaPointe is a scholar working on Pathology and Forensic Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Lawrence C. LaPointe has authored 20 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 14 papers in Cancer Research and 10 papers in Molecular Biology. Recurrent topics in Lawrence C. LaPointe's work include Genetic factors in colorectal cancer (14 papers), Cancer Genomics and Diagnostics (13 papers) and Colorectal Cancer Screening and Detection (8 papers). Lawrence C. LaPointe is often cited by papers focused on Genetic factors in colorectal cancer (14 papers), Cancer Genomics and Diagnostics (13 papers) and Colorectal Cancer Screening and Detection (8 papers). Lawrence C. LaPointe collaborates with scholars based in Australia, United States and Netherlands. Lawrence C. LaPointe's co-authors include Graeme P. Young, Susanne K. Pedersen, Peter L. Molloy, Robert Dunne, Rohan T. Baker, Thu Ho, Aidan McEvoy, Erin L. Symonds, David H. Murray and Lloyd D. Graham and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Lawrence C. LaPointe

20 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence C. LaPointe Australia	14	609	563	330	273	123	20	907
Mai‐Britt W. Ørntoft Denmark	9	446 0.7×	244 0.4×	381 1.2×	269 1.0×	190 1.5×	20	685
Maria Popoli United States	5	358 0.6×	178 0.3×	286 0.9×	211 0.8×	129 1.0×	13	577
Anatoliy A. Melnikov United States	12	434 0.7×	515 0.9×	254 0.8×	115 0.4×	129 1.0×	14	738
Concepción Muñoz Spain	9	224 0.4×	341 0.6×	220 0.7×	75 0.3×	81 0.7×	13	533
Emily E. Lyons United States	6	386 0.6×	147 0.3×	511 1.5×	52 0.2×	132 1.1×	7	582
Samia Melaabi France	10	199 0.3×	152 0.3×	200 0.6×	120 0.4×	166 1.3×	22	456
Jorma J. de Ronde Netherlands	10	390 0.6×	213 0.4×	272 0.8×	163 0.6×	69 0.6×	12	598
E Gabrielson United States	8	191 0.3×	183 0.3×	323 1.0×	170 0.6×	121 1.0×	9	635

Countries citing papers authored by Lawrence C. LaPointe

Since Specialization

Citations

This map shows the geographic impact of Lawrence C. LaPointe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence C. LaPointe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence C. LaPointe more than expected).

Fields of papers citing papers by Lawrence C. LaPointe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence C. LaPointe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence C. LaPointe. The network helps show where Lawrence C. LaPointe may publish in the future.

Co-authorship network of co-authors of Lawrence C. LaPointe

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence C. LaPointe. A scholar is included among the top collaborators of Lawrence C. LaPointe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence C. LaPointe. Lawrence C. LaPointe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pedersen, Susanne K., et al.. (2022). Detection of methylated BCAT1 and IKZF1 after curative‐intent treatment as a prognostic indicator for colorectal cancer recurrence. Cancer Medicine. 12(2). 1319–1329. 14 indexed citations

Pedersen, Susanne K., Benjamin Musher, Lawrence C. LaPointe, et al.. (2022). Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1. Cancer. 128(10). 1921–1928. 11 indexed citations

Young, Graeme P., Erin L. Symonds, Hans Jørgen Nielsen, et al.. (2021). Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer. Clinical Epigenetics. 13(1). 14–14. 20 indexed citations

Vucetic, Zivjena, et al.. (2021). Clinical performance of methylation-based liquid biopsy test COLVERA after optimization of test interpretation rules.. Journal of Clinical Oncology. 39(15_suppl). 3546–3546. 2 indexed citations

Musher, Benjamin, Joshua Melson, David W. Chan, et al.. (2020). Evaluation of Circulating Tumor DNA for Methylated BCAT1 and IKZF1 to Detect Recurrence of Stage II/Stage III Colorectal Cancer (CRC). Cancer Epidemiology Biomarkers & Prevention. 29(12). 2702–2709. 25 indexed citations

Symonds, Erin L., Susanne K. Pedersen, David H. Murray, et al.. (2020). Circulating epigenetic biomarkers for detection of recurrent colorectal cancer. Cancer. 126(7). 1460–1469. 33 indexed citations

Symonds, Erin L., Susanne K. Pedersen, David J. Murray, et al.. (2019). Performance comparison of the methylated BCAT1/IKZF1 ctDNA test (COLVERA) with the CEA assay for detection of recurrent colorectal cancer.. Journal of Clinical Oncology. 37(15_suppl). 3589–3589. 1 indexed citations

Mitchell, Susan M., Thu Ho, Rohan T. Baker, et al.. (2016). Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer. Genes. 7(12). 125–125. 43 indexed citations

Symonds, Erin L., Susanne K. Pedersen, Stephen R. Cole, et al.. (2016). Improving Participation in Colorectal Cancer Screening: a Randomised Controlled Trial of Sequential Offers of Faecal then Blood Based Non-Invasive Tests. Asian Pacific Journal of Cancer Prevention. 16(18). 8455–8460. 17 indexed citations

10.

Symonds, Erin L., Susanne K. Pedersen, Rohan T. Baker, et al.. (2016). A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia. Clinical and Translational Gastroenterology. 7(1). e137–e137. 79 indexed citations

11.

Pedersen, Susanne K., Erin L. Symonds, Rohan T. Baker, et al.. (2015). Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia. BMC Cancer. 15(1). 654–654. 101 indexed citations

12.

Pedersen, Susanne K., Rohan T. Baker, Aidan McEvoy, et al.. (2015). A Two-Gene Blood Test for Methylated DNA Sensitive for Colorectal Cancer. PLoS ONE. 10(4). e0125041–e0125041. 59 indexed citations

13.

Symonds, Erin L., Graeme P. Young, Stephen R. Cole, et al.. (2015). Mo1943 Comparison of a Methylated Two-Gene (BCAT1-IKZF1) Blood Test to FIT for Detection of Colorectal Neoplasia. Gastroenterology. 148(4). S–746. 1 indexed citations

14.

Pedersen, Susanne K., Susan M. Mitchell, Lloyd D. Graham, et al.. (2014). CAHM, a long non-coding RNA gene hypermethylated in colorectal neoplasia. Epigenetics. 9(8). 1071–1082. 39 indexed citations

15.

Mitchell, Susan M., Jason P. Ross, Horace R. Drew, et al.. (2014). A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer. 14(1). 54–54. 131 indexed citations

16.

Young, Graeme P., Susanne K. Pedersen, Evelien Dekker, et al.. (2014). 228 Evaluation of a 2-Gene (IKZF1 and BCAT1) DNA Blood Test for Detection of Colorectal Cancer. Gastroenterology. 146(5). S–56. 2 indexed citations

17.

Young, Graeme P., Susanne K. Pedersen, Evelien Dekker, et al.. (2014). 228 Evaluation of a 2-Gene (IKZF1 and BCAT1) DNA Blood Test for Detection of Colorectal Cancer. Gastrointestinal Endoscopy. 79(5). AB125–AB125. 1 indexed citations

18.

LaPointe, Lawrence C., Susanne K. Pedersen, Robert Dunne, et al.. (2012). Discovery and Validation of Molecular Biomarkers for Colorectal Adenomas and Cancer with Application to Blood Testing. PLoS ONE. 7(1). e29059–e29059. 35 indexed citations

19.

Graham, Lloyd D., Susanne K. Pedersen, Gabrielle Brown, et al.. (2011). Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas. Genes & Cancer. 2(8). 829–840. 220 indexed citations

20.

LaPointe, Lawrence C., Robert Dunne, Daniel L. Worthley, et al.. (2007). Map of differential transcript expression in the normal human large intestine. Physiological Genomics. 33(1). 50–64. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mai‐Britt W. Ørntoft Breakdown of academic impact, for papers by Maria Popoli Breakdown of academic impact, for papers by Anatoliy A. Melnikov Breakdown of academic impact, for papers by Concepción Muñoz Breakdown of academic impact, for papers by Emily E. Lyons Breakdown of academic impact, for papers by Samia Melaabi Breakdown of academic impact, for papers by Jorma J. de Ronde Breakdown of academic impact, for papers by E Gabrielson